Factor H binding protein is a 27 kDa lipoprotein of Neisseria meningitidis discovered while screening the bacterial genome for vaccine candidates. In addition to being an important component of a vaccine against meningococcus in late stage of development, the protein is essential for pathogenesis because it allows the bacterium to survive and grow in human blood by binding the human complement factor H. We recently reported the solution structure of the carboxyl-terminal domain of factor H binding protein, which contains the immunodominant epitopes. In the present study we report the structure of the full-length molecule, determined by nuclear magnetic resonance spectroscopy. The protein is composed of two independent barrels connected by a short link. Mapping the residues recognized by monoclonal antibodies with bactericidal or factor H binding inhibition properties allowed to predict the sites involved in the function of the protein. The structure therefore provides the basis for designing improved vaccine molecules.
). On the contrary, the development of a vaccine against serogroup B, still responsible for a significant percentage of invasive diseases, has been protracted due to the immunologic cross-reactivity of B polysaccharide with human tissues. Recently, new perspectives to meningococcal B (menB) prevention have been opened by the identification of suitable protein-based vaccine antigens identified by mining the bacterial genome ( 4 ). One of the most promising antigens is the factor H binding protein (fHbp). This is a membrane-anchored lipoprotein ( 3; 5; 6 ), which binds human factor H, a negative regulator of the alternative complement activation pathway. ( 7 ). Coating the bacterial surface with factor H, allows the bacterium to mimic a human tissue and avoid complement-mediated lysis. fHbp is expressed by all the pathogenic strains of N. meningitidis and can be classified in three distinct sequence variants ( 5 ). This diversity has a remarkable impact on the immunological properties of fHbp, given that members of each variant induce a strong protective immunity against meningococcal strains carrying homologous alleles, but are ineffective against strains, which express distantly related fHbp alleles. A number of studies using monoclonal antibodies have identified residues involved in protective epitopes and factor H binding. Initially Arg204 and the cluster Glu146-Arg149 were identified as targets of bactericidal monoclonal antibodies elicited by the recombinant fHbp of variant 1 (v.1) ( 8; 9 ). The same epitope was later shown to contain also Phe277, Gly228, Lys230 and Glu233 ( ( 11 ) and identified Gly121 and Lys122 as critical for binding by antiv.1 antibodies. Ser216 was shown to be important for variant 2 (v.2), while amino acid positions 174, 180 and 192 were shown to be key residues to discriminate between variant 2 and variant 3 (v.3) . While the molecular distribution of residues from 141 to 255 was appreciable onto the structure of Cterminus domain whose solution structure was already solved ( 12 ), spatial arrangement of Gly121 and Lys122 remained so far undetermined. This incompleteness of information hampered a detailed evaluation of the molecular distribution of variantspecific epitopes, as well as the opportunity to rationalize the reported differences in the ability of monoclonals to induce complement-mediate killing and inhibit the protein binding to human factor H ( 11 ).
In the present study, we determined the structure of the full-length fHbp by nuclear magnetic resonance (NMR), which improves the knowledge about the distribution of protective epitopes on the protein surface and provides useful indications on the possible localization of the factor H (fH) binding site.
EXPERIMENTAL PROCEDURES
Sample production and NMR measurements. Recombinant fHbp v.1 (residues Met7-Gln255) was expressed in Escherichia coli as already described . Analytical gel filtration analysis showed that the recombinant protein was eluted in fractions corresponding to a monomeric state of the molecule. ESI-MS spectrum indicated a mass of 27281.43 Da, which corresponded to the cloned construct. NMR spectra were acquired at 298 K on Avance 900, 700 and 500 MHz Bruker spectrometers, all equipped with a triple resonance cryoprobe. N HSQC experiment performed on the protein previously extensively dialyzed against deuterated buffer. Hydrogen bond constraints for the slowly deuterium exchanging amide protons of the β-strands were introduced at later steps of structure calculations. Structure calculations were performed using the program CYANA-2.1 16 . 900 random conformers were annealed in 13000 steps. The χ tensor parameters were obtained with FANTAORIENT and they were optimized through iterative cycles of PSEUDOCYANA until convergence 17 . The family of the best 30 structures in terms of target function was then subjected to restrained energy minimization with AMBER 10.0 Package in explicit water solvent 18 . The distance and torsion angle constraints and the RDCs were applied with force constants of 50 kcal mol -1 Å -2 and 32 kcal mol Heteronuclear relaxation rates, whose values are affected by the dynamic properties of the molecule, were essentially homogeneous along the entire polypeptide sequence, with the exception of residues located at the C-and N-termini and some loops. The correlation time for the molecule tumbling (τ c ), as estimated from the R 2 /R 1 ratio, is 20.3 ± 1.5 ns, consistent with the molecular weight of the protein being in the monomeric state.
The solution structure of the full length fHbp consisted of two domains, fHbpN (residues 8-136) and fHbpC (residues 141-255) composed of 10 and 8 antiparallel β strands, respectively. fHbpN and fHbpC were connected by a five residue linker, and had a topology of secondary structure elements as shown in Figure 1A , with an overall 3D structure as shown in Fig, 1B . Both domains are structurally well defined, with only few loops showing some conformational disorder (Fig. S2) . From heteronuclear relaxation measurements (Fig. S3 ), it appears that most of these loop regions, and in particular those including residues 85-90 and 118-123 located in the N-terminal domain, have significantly lower heteronuclear NOE values as a consequence of local motions in the ns-ps timescale. Consistently, they were characterized by a very low number of long range (Fig. S4 ) and consequentely their conformation was less defined (Fig. S2) .
The fHbpN domain has an elongated barrellike structure with length of about 49 Å and width 22 Å. It is organized in 6 antiparallel β strands of different lengths (β 2 (45-50), β 3 (53-58), β 5 (72-84), β 6 (87-100), β 7 (104-111), β 8 (128-136) forming an extended β-sheet and two short β-strands (β 1 (33-35) and β 4 (62-64), which face the β-sheet and a short Nterminal α helix (16) (17) (18) (19) (20) (21) . In 50% of the family conformers a short β-hairpin, including residues 114-116 (β 7 ' ) and 123-125 (β 8 ' ) is observed between β7 and β8 (Fig. 1A) whose presence is supported by the CSI analysis. The core of fHbpN is characterized by several hydrophobic interactions, which involve aromatic and aliphatic residues. In particular, hydrophobic contacts are present between residues clustered on one side of the β-sheet, (Leu46, Leu 48 (β 2 ), Ala53 and Tyr57 (β 3 ), Phe76, Phe78 (β 5 ), Phe96 Val98 (β 6 ), Ala105, Phe109 (β 7 ), Ala 135(β 8 ) and those on the two other β strands β 1 (Leu34 and Leu36) and β 4 (Leu63), determining the spatial proximity of the two regions and the overall shape of the N-terminal domain. Further long range interactions between residues Leu34, Thr35 and Asp133, Ala135 mantain β   close to β 8 stabilizing the overall structure. The three dimensional arrangement of the β-strands defines a hydrophobic core, which is closed on one side by helix α 1 . Contacts between some residues located in β 3 , β 4 and β 5 and those in helix α 1 are present, which anchor such helix to the rest of the protein. The latter interactions define the conformation of a long loop (segment 22-32), which is completely solvent exposed and rich in charged residues. The latter loop, although stabilized by the contacts of two hydrophobic residues (Leu24 and Leu31) with the rest of the protein, experiences high conformational disorder. Also the region between β 5 and β 6 , opposite to the N-terminal helix, is solvent exposed despite it is rich in hydrophobic residues ( Fig 1C) .
The C-terminal domain fHbpC is constituted by an eight-stranded antiparallel β-barrel (141-255), whose strands are connected by loops of variable lengths. The same arrangement was previously found in the solution structure of the same domain in the isolate construct ( 12 ). The 3 10 -helix present in the solution structure of isolated fHbpC is still present in the majority of 30 of the full length conformers, although shorter (141-143) with respect to that observed the isolated fHbpC (138-141). Sizable variations for the backbone NH chemical shifts of fHbpC in the two constructs(> 0.25 ppm as combined chemical shifts) were observed on β 7 , β 8 , β 9 , β 14 , β 15 and β 16 (Fig.S6 ). The largest differences were observed for residues located in β 7 , β 8 , which formed a long disordered tail in the isolated fHbpC. The other four β-strands, of the C-terminal domain, are located on the one side of the β-barrel and define the domain-domain interface. Interestingly, residues located in β 9 , β 14 , β 15  and  β 16 formed a hydrophobic patch in fHbp C molecule. The present structure confirms our previous insights on the role of this region of the β-barrel ( 12 ). The domain-domain interface, formed by about 850 Å 2 of buried surface, is stabilized by intermolecular contacts involving exclusively hydrophobic amino acids (Leu106, Tyr 99, Phe129, Ile134, N-terminal domain; Thr155, Phe157, Phe227, Leu251, C-terminal domain, Fig. 1C ). About seventy long range inter-domains NOEs were found, which defined together with the RDCs, the domains reciprocal orientation. DISCUSSION Human complement is the first barrier of innate immunity, and kills infectious agents when they try to invade the bloodstream ( 26 ). To do this, it attacks anything which is not self. Factor H, and C4b are complement components that allow the system to distinguish between invasive agents and self tissues by coating the latter and avoid the complement attack. During the evolutionary battle for survival, virtually all pathogens have found multiple and redundant way to escape the complement-mediated killing ( 27 ) . One of the most popular strategies among pathogens is to avoid complement by mimicking host surfaces, covering themselves with factor H. fHbp of N. meningitidis is the typical example of this class of molecules. By binding human factor H this protein allows the bacterium to survive and grow in human blood and cause a terrible disease. This property, together with the ability to induce in humans a strong antibody response, makes this protein an attractive vaccine antigen able to induce antibodies with double function: killing the bacterium by direct activation of the classical complement cascade, and preventing the formation of fH-fHbp complex on the surface of the bacterium. Based on the knowledge of the complete structure of fHbp, we can identify the location of the variable amino acids ( Fig. 2A) , the residues involved in binding protective monoclonal antibodies (Fig. 2B) , the region bound by antibodies against variant 1 (Fig. 2C) , the region bound by antibodies against variant 2 (Fig. 2D) , and the residues recognized by the antibodies that inhibit Factor H binding (Fig.  2E) . The variable residues ( Fig. 2A) cluster in the upper part of the molecule. This is consistent with a model where the protein is anchored to the bacterial cell wall through the palmitic acid extension of Cys1 ( 5 ) and exposes the upper part to the outside where it is under the selective pressure of the immune system. Accordingly, the amino acids known to be part of epitopes ( 8; 9; 10; 11 ) are all localized in correspondence of the zone of higher variability (Fig.2B) . Arg204, Gly121 and the loop formed by Glu146 until Arg149 were identified as involved in the formation of bactericidal v.1 epitopes ( 8; 9; 11 ). Arg204 is located in the loop between β 12 and β 13, while the segment 146-149 corresponds to the region connecting the two fHbp domains and containing the second short helix α2. Gly121, which was localized in the disordered region of the isolate fHbpC, occupies now the loop between β7' and β8' strands. NMR driven epitope mapping carried out on the isolate fHbpC identified Phe141, Lys199, Arg204, Glu146-Arg149, Phe227, Lys230 and Glu233 as part of the same epitope recognized by the bactericidal monoclonal antibody Mab502 elicited by fFbp v.1 ( 10 ). The distribution of these residues on the full length protein supports the hypothesis that fHbpC contain the major part of the native epitope, being all these residues still accessible in the whole fHbp with the exception of Phe227 and Glu233, shielded now by the presence of the N-terminal domain. Epitopes of v.2 and v.3 have recently shown to include residues in position 174, 216, 180 and 192. Although none of the corresponding monoclonal antibodies was bactericidal individually, nevertheless some pairs of them were able to perform meningococcal killing when combined. The same was true for a pairs of monoclonal antibodies raised against v.1( 11 ). We tried to identify the fHbp regions targeted by these pairs of bactericidal monoclonal antibodies, placing residues recognized by each component at the centre of a molecular area of 950 A 2 , value chosen as representative value of the average size for a protein conformational epitope ( 28; 29; 30; 31 ). The interesting observation that the bactericidal epitopes crucial for killing of v.1 and v.2 are only partially overlapping, suggests that it may be possible to engineer molecules containing epitopes of all variant proteins (Fig. 2C and D) . Finally, Fig. 2E shows that the residues recognized by the monoclonal antibodies that inhibit Factor H binding ( 11 ), are located In the upper part of both in the N terminal and C terminal part of the molecule, suggesting that this region is involved in the interaction with Factor H. In conclusion, the complete structure of fHpb allowed to map residues involved in important functions such as binding to Factor H and eliciting bactericidal antibodies, and provides the basis to understand the molecular mechanisms behind the function of this important molecule. The structure may be used to design improved vaccine antigens.
FOOTNOTES
The atomic coordinates (code 2KC0) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/). MIUR-FIRB n. RBLA032ZM7 is gratefully acknowledged. Fig.1. A Topology diagram of N NOE respectively. All 3D and 2D spectra were processed using the standard Bruker software TOPSPIN and analyzed through CARA and XEASY programs (22) (23) (24) 
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